// App-Quantinova.ai

: Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Pediatric Hematologic Malignancies

Researchers

Presenter

  • Gerardo Lopez-Hernandez

Principal Investigators

  • Norma Lopez-Santiago

  • Alberto Olaya-Vargas

  • Martn Prez-Garca

  • Rosa Mara Nideshda Ramrez-Uribe

  • Hayde del Pilar Salazar-Rosales

  • ngeles Del Campo-Martnez

  • Laura Alejandra Xiqui-Jardines

Medical Centers

  • Division of Hematology/Oncology, Bone Marrow Transplant unit, National Pediatrics Institute, Ciudad de México, Mexico

  • Division of Hematology/Oncology, Hematology Service, National Pediatrics Institute, Ciudad de México, Mexico

  • Division of Hematology/Oncology, Bone Marrow Transplant unit, National Pediatrics Institute, Ciudad de México, Mexico

  • Division of Hematology/Oncology, Bone Marrow Transplant unit, National Pediatrics Institute, Ciudad de México, Mexico

  • Division of Hematology/Oncology, Hematology Service, National Pediatrics Institute, Ciudad de México, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Hematological malignancies

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 34

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • fludarabine tablet

  • Tacrolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved